Transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of severe aortic stenosis and is now the default option for patients with elevated surgical risk. Since the first valve implantation in 2002, there have been dramatic improvements in both technical/procedural aspects and equipment used which have naturally led to improved outcomes1,2. The procedure has evolved and become streamlined with “minimal” TAVI performed in many centres. Preprocedural computed tomography (CT) sizing, procedural use of conscious sedation, lower profile sheaths and improvements in vascular closure devices have led to mortality and morbidity reductions and earlier discharge times (often within 48 ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com